Lamy et al.37 demonstrated that in breast cancer cells, the expression/activity of several iron-related proteins, such as ferritin, hepcidin, and FPN (also known as Ireg1), are deregulated and that these alterations may have a prognostic impact on patients with breast cancer. This evidence concerns the gene HAMP and breast carcinoma.